Was very struck by Gerald's candid discussing the possibility of selling LYMPRO once the applications with FDA are completed, or nearly so. This is a huge step forward, and is indicative of the BODs and BOAs confidence in MANF and the phenoguard pipeline. There is absolute confidence in the completion of the CLIA study, and the application with FDA for approval with huge revenue potential. Why on earth would they be so willing to sell their revenue generator? We have to remember that only the mngt is privy to everything that is in process, and that as we heard again from Gerald yesterday, he cannot disclose information in a number of areas. One thing is for sure there is a great deal going on behind the scenes that warrants this paradigm shift. I believe we are going to see some jaw-dropping news before the end of the year, maybe before the shareholder's meeting on the 22nd! Gerald showed an amazing grasp of the complexities of AMBS business plan yesterday! I was impressed!!